Palatinose as a potential parenteral nutrient: Its metabolic effects and fate after oral and intravenous administration to dogs.
スポンサーリンク
概要
- 論文の詳細を見る
Palatinose (6-O-α-D-glucopyranosyl-D-fructose) is a na-turally occurring compound which may be valuable as both a sweetener and parenteral nutrient. Its advantage over maltose is that its hydrolysis generates both fructose and glucose. In the present study, conducted with a view to possible clinical use, its metabolic effects and fate after iv injection were investigated. Using dogs as the experimental model, it was found that the behavior of parenterally administered palatinose is in many respects similar to maltose and is likely to be clinically valuable. Importantly, hypertriglyceridemia, a side effect of fructose administration, did not occur, indicating that palatinose may be superior to the use of fructose alone.
- 財団法人 学会誌刊行センターの論文
著者
-
山下 亀次郎
Department Of Internal Medicine Institute Of Clinical Medicine University Of Tsukuba School Of Medic
-
川井 紘一
Department of Interanal Medicine, Institute of Clinical Medicine, University of Tsukuba
-
奥田 諭吉
Department of Interanal Medicine, Institute of Clinical Medicine, University of Tsukuba
-
千葉 之宣
Department of Interanal Medicine, Institute of Clinical Medicine, University of Tsukuba
-
山下 亀次郎
Department of Interanal Medicine, Institute of Clinical Medicine, University of Tsukuba
関連論文
- 甲状腺スクリーニング中に発見した微小甲状腺髄様癌の一散発症例
- Palatinose as a potential parenteral nutrient: Its metabolic effects and fate after oral and intravenous administration to dogs.